Answers are grounded in this paper and cite their sources.
Epitranscriptomic modifications of RNA, particularly N6-methyladenosine (m6A), have emerged as pivotal players in cancer biology. RNA m6A modifications dynamically regulate gene expression, influencing various aspects of RNA processing, stability, and translation. In the context of cancer, dysregulation of RNA m6A modification has been implicated in tumorigenesis, metastasis, therapy resistance, and the tumor micro environment. This review provides an in-depth exploration of the intricate relationship between RNA m6A modifications and cancer.
No takes yet. Share an insight, caveat, or question.
Afrasiyab et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: